Clinical trial
Efficacy and Safety of Lumiracoxib
NCT00267215 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00267215 |
|---|---|
| Title | Efficacy and Safety of Lumiracoxib |
| Official title | A One-week Multicenter, Multiple-dose, Randomized, Double-blind, Double-dummy, Parallel-group Comparison of the Analgesic Efficacy and Safety of Lumiracoxib (COX189), Celecoxib, and Placebo in the Treatment of Osteoarthritis of the Knee |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Lumiracoxib |
| Enrollment | 330 |
| Start date | Nov 1, 2000 |
| Primary completion | Feb 1, 2001 |
| First posted | Dec 20, 2005 |
| Last update posted | May 21, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: